Navigation Links
Systemizers Have A Higher Risk Of Children Suffering From Autism
Post Your Comments:
(Date:1/9/2009)..., Fla. -- A unique discovery in a Florida State Un...is for research with the potential to one day help...eases in the tissue where they are forming. , Ja...iences at the College of Medicine, has received a ...stitutes of Health to pursue her work. Horabin rec...
(Date:1/9/2009)... Blackbaud, Inc. today announced that it...ndation of Canada that will create a unified natio... Charleston, S.C. (Vocus) January 9, 2009 -- Bla... it will develop a custom solution for The Kidney ...tional CRM and web presence., , , , ,"We sel...
(Date:1/9/2009)...HIA) Efforts to fight the toll of cardiac arrest ...bystander CPR education and improvement, public de...ut new research from the University of Pennsylvani...re patients are cared for after being resuscitated...lowing these incidents, which takes the lives of m...
(Date:1/9/2009)... Use It As Both a Membership Card and Debit Card f... 9 UPMC Health Plan eliminates the...Flexible Spending Account (FSA) with its new My F...to Western Pennsylvania - serves as both a health ...t-of-pocket health care expenses. , , The My F...
Breaking Medicine News(10 mins):Health News:Researcher wins $1.2 million grant for gene regulation work 2Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 2Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 3Health News:Blackbaud to Deliver National CRM Database and Bilingual Website for The Kidney Foundation of Canada 4Health News:Penn study: Chances of surviving cardiac arrest depend on where patients are treated 2Health News:Penn study: Chances of surviving cardiac arrest depend on where patients are treated 3Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 2Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 3
...erala as an ideal destination for medical tourism,...ad shows in the US, Britain, Dubai, Muscat, Kuwait...red for this because it has to be systematic and w...f Indian Industries) to give inputs to the draft o...
...rofessor of medicine and physiology and director o...rch at McGill University in Montreal//, and collea...levant in geriatric medicine and psychiatry. Eld...ti-depressants regularly run a risk of increased f...
...niversity of Illinois at Urbana-Champaign have com...hod // that is used for optical microscopy, which ...images from hazy and unclear data. The technique,...ure Microscopy, ISAM is beneficial to optical micr...
...ts of a deadly superbug that attacks healthy young... is a vital first step in attempts to find a cure ... resistant to current antibiotic treatments. Alr...aths in Britain, experts fear we are in the early ...
Other Medicine News:Health News:Prozac-popping Elders at Higher Risk of Fractures 2Health News:New Computed Imaging Technique Uses Hazy Images to Improve View 2
(Date:1/8/2009)...l dose in an ongoing Phase Ib trial demonstrated a...ays , , Conference Call Today at 8:30AM EST ,...nadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) toda...going Phase Ib clinical trial of ANA598, the Compa...ibitor. ANA598 was very well-tolerated and demons...
(Date:1/7/2009)...wire-USNewswire/ -- Scientists have identified mut... relapse in children with acute lymphoblastic leuk...further research is needed to determine how change... leukemia relapse, the findings are likely to prov...s the risk of treatment failure. By using a molecu...
(Date:1/7/2009)...wire/ -- ImQuest Life Sciences announced today the...e Food and Drug Administration to initiate human c...inhibitor IQP-0410. ImQuest anticipates initiating...9. IQP-0410 is a novel small molecule inhibitor of...se transcriptase inhibitor (NNRTI). The compound p...
(Date:1/7/2009)...- Tiantan Puhua Hospital Stem Cells Center ( http:...n using stem cells to effectively treat neurologic...erienced additions to its medical and research sta...ent capabilities for growing numbers of incoming i...ude the distinguished Dr. Jiang Ping, who was name...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 1Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 2Mitigating Medical Identity Theft 3A AHIMA Journal Provides Patient Tools to Secure Health Information 23459 3Two National Health Organizations to Recognize the Nations Best Health Systems for Patient Safety Leadership 23457 1Two National Health Organizations to Recognize the Nations Best Health Systems for Patient Safety Leadership 23457 2Two National Health Organizations to Recognize the Nations Best Health Systems for Patient Safety Leadership 23457 3Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 1Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 2Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 3Study Measures Real World Comparative Effectiveness of Asthma Controller Medications 23455 4Associates of Cape Cod 28ACC 29 and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 23453 1Associates of Cape Cod 28ACC 29 and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 23453 2Associates of Cape Cod 28ACC 29 and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform 23453 3
...ddress Growing Problem of Antibiotic Resistance,Pu...h Columbia, March 26, 2007 /PRNewswire/ --,Inimex ...the first,immune system trigger to cure infections...o a paper published in the April 2007,issue of Nat...he work of Inimex and its,co-founders Dr. Bob Hanc...
... Outpatient Infusion Study in Patients with,Chroni...rican,College of Cardiology 56th Annual Scientific..., March 25, 2007,/PRNewswire/ -- Scios Inc. announ...2 study of nesiritide (NATRECOR(R)) showed a,neutr...death and,cardiorenal hospitalization at 12 weeks,...
Other Medicine Technology:Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
Sera available in three levels for the control of accuracy and precision for up to 31 analytes
Human based material available in two levels for the control of accuracy and precision for upto 23 analytes.
CRP Liquid Conrtols level 2
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma
Medicine Products: